Report Categories
View AllRecent Articles
View All
FCT First Trust Senior Floating Rate Income Fund II posts 418 percent year over year Q1 2026 revenue drop shares edge higher
DMarket HEPS Stock Key Takeaways 071 20260415
Broadway Fin BYFC Stock Fair Value Trend Strengthens 20260415
Is Odysightai ODYS stock creating a trading range Steep 104pct EPS miss for Odysightai Inc on cost pressures
Chatham REIT CLDT Stock Price and Volume 234 20260418
OVLY Oak Valley Bancorp CA posts Q3 2023 EPS of 089 shares dip 017 following quarterly earnings release
Is Asana ASAN stock a good opportunity for entry Touches Low 20260418
Market Action Tech leads broad gains as consumer stocks lag mild rally
Is Inhibrx Biosciences INBX stock trending consistently Inhibrx Biosciences Inc posts narrow EPS beat no quarterly revenue disclosed
KE Kimball Electronics Inc posts Q1 2026 earnings beat but doubledigit year over year revenue decline pulls shares slightly lower
Is Intrusion INTZ stock heading higher Trades Lower 20260420
Is Gilat GILT stock showing technical strength Q4 2025 EPS Tops Views
Best Buy Co Inc BBY Valuation Assessment Following Recent ShortTerm Share Price Outperformance
Is AC Spirits AGCC stock positioned for growth AC Spirits sees strong premium spirit demand in key markets
Boxlight BOXL Stock Trade Ticket Mini Selloff 20260420
MUZE Muzero signals upcoming strategic pivot to niche SaaS markets as quarterly earnings release looms
Vertex Pharmaceuticals Incorporated VRTX Price Target Upgrade and Expanded CF Therapy Approval Support Bullish Fundamental Trajectory
JKS JinkoSolar shares climb 1085 percent despite steep Q4 2025 EPS miss and 223 percent yearoveryear revenue drop
Fusemachines FUSEW Stock Technical Momentum 3938 20260423
SKYW SkyWest notches Q4 2025 EPS beat and 15 percent YoY revenue growth shares fall 286 percent
Marriott International MAR Stock Why It Could Distribute 038 20260420
MDXH MDxHealth SA Q4 2025 earnings miss estimates 198 YoY revenue growth fails to stop 519 share drop
Gogoro GGR Stock DCF Valuation Slight Rise 20260420
HBT HBT Financial posts 69 percent Q4 2025 EPS miss with its stock edging slightly higher in regular trading
IOBT IO Biotech reports 60 percent narrower Q3 2025 loss than estimates shares remain unchanged